课题基金 / 基金详情

Novel G-protein coupled receptor interactions and complexes with distinct function and pharmacology

Novel G-protein coupled receptor interactions and complexes with distinct function and pharmacology
具有独特功能和药理学的新型 G 蛋白偶联受体相互作用和复合物
批准号:
nhmrc : 212065
负责人:
Karin Eidne
金额:
$16.45万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2002
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2002-01-01 至 2004-12-31

项目摘要

项目成果

Karin Eidne的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
G protein coupled receptors (GPCRs) are the target in the human body for most of today's medicines. Almost all pharmaceutical companies market drugs that are GPCR agonists or antagonists aimed at diverse disease states. Our research is focused on the molecular basis of drug recognition and signalling by GPCRs. We use genetic engineering techniques to create new receptors and mutant receptors in order to identify the functional domains of these signalling molecules. We have recently established a novel approach based on proximity-dependent fluorescent technologies to explore receptor interactions and have described the formation of functional G-protein coupled complexes in living cells. This project is to discover new receptor combinations which could potentially affect signalling pathways and redirect cellular responses. Investigation of the mechanisms involved in turning on and off the body s response to stimuli would provide valuable information for drug design and treatment of GPCR-related conditions. We have chosen to use two GPCRs as models for our study of the mechanisms controlling receptor driven cellular responses and the interactions between cellular components-proteins behind this control. Firstly, the gonadotropin releasing hormone receptor (GnRHR), a protein located in the pituitary which is pivotal in the control of reproduction and secondly, the thyrotropin releasing hormone receptor (TRHR), similarly located and involved in modulating thyroid and metabolic function. We will investigate the way these receptors interact with other cellular proteins in order for them to function. Ultimately this will provide a better understanding of how these clinically important proteins function and pave the way for the development of clinical applications that target these receptor systems, resulting in the effective treatment of a wide range of conditions and diseases, including pain, migraine, certain forms of cancer, neurological and reproductive disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulator of G-protein Signalling-5: a key modulator of vascular maturation and the
  • 批准号:
    nhmrc : 458627
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $36.57万
  • 财政年份:
    2007
  • 负责人:
    Karin Eidne
  • 依托单位:
Novel interactions between GnRH receptor and E2F4 transcription factor.
  • 批准号:
    nhmrc : 303256
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $30.86万
  • 财政年份:
    2004
  • 负责人:
    Karin Eidne
  • 依托单位:
Molecular mechanisms underlying G protein coupled receptor signaling
  • 批准号:
    nhmrc : 299811
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $39.81万
  • 财政年份:
    2004
  • 负责人:
    Karin Eidne
  • 依托单位:
Equipment Grant 2002
  • 批准号:
    nhmrc : 264402
  • 项目类别:
    NHMRC Infrastructure Grants
  • 资助金额:
    $0.69万
  • 财政年份:
    2003
  • 负责人:
    Karin Eidne
  • 依托单位:
国内基金
海外基金
子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对 话促进子宫腺肌病蜕膜化缺陷的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    吕海宁
  • 依托单位:
有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
  • 批准号:
    32372636
  • 项目类别:
    面上项目
  • 资助金额:
    50.00万元
  • 批准年份:
    2023
  • 负责人:
    郭慧娟
  • 依托单位:
原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
  • 批准号:
    82371054
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    郭涛
  • 依托单位:
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
  • 批准号:
    82370976
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    郑凌艳
  • 依托单位: